The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of anti-HER2 agents in the treatment of biliary tract cancers: A systematic review.
 
Nikolas Naleid
No Relationships to Disclose
 
Omkar Pawar
No Relationships to Disclose
 
Sakti Chakrabarti
Honoraria - BioMedical Insights; Cancer Expert Now; HalioDx; Histosonics; Natera; omnihealth Media; QED Therapeutics
Speakers' Bureau - Bristol Myers Squibb; Merck; Natera; Seagen; Takeda
Research Funding - Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Binacea
 
Zhaohui Jin
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca (Inst); Elevar Therapeutics (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Lilly (Inst)
 
Ankit Mangla
Consulting or Advisory Role - SpringWorks Therapeutics
Research Funding - BioAtla; Boehringer Ingelheim; Dragonfly Therapeutics; Pfizer; Regeneron; SpringWorks Therapeutics; TRACON Pharma
 
Amit Mahipal
Consulting or Advisory Role - AstraZeneca/MedImmune; Elevar Therapeutics; Guardant Health; Taiho Oncology
Speakers' Bureau - AstraZeneca; Taiho Oncology
Research Funding - Taiho Pharmaceutical